Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12616001628437Phase 4Completed
Phase 4, randomised trial of ropivacaine in thyroid disease (2 arms), sponsored by Yanqing Chen. Primary endpoint: Quality of recovery. Started Jan 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12616001628437.